This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Innovation & Partnering Summit
May 16-18, 2023
Delivered as a Hybrid EventBoston, MA

Megan Murphy
Global Lead, Patient Advocacy at Biogen


Megan Murphy has been working in Patient Advocacy for more than 15 years, both in industry and the non-profit space. During her tenure at Biogen, she has led patient advocacy across a number of therapeutic areas in the rare disease space, including ALS, PSP, and Inherited Retinal Disorders. Megan has a passion for creating meaningful relationships with patient communities, leveraging her years of advocacy in rare cancers.

Agenda Sessions

  • Is AI the silver bullet to Clinical Trials in Rare Diseases?